Radiotherapy can lead to immunogenic cell death that release TAAs (6), and induce increased expression of MHC-I molecules in tumour cells and increase their sensitivity to CTL killing (39), as well as activate the DNA-cGAS-STING pathway to enhance anti-tumour T-cell responses by DCs (7). The gene discussed is STING1; the disease is neoplasm.